Upexi Inc

詳細情報 Upexi Inc 企業名

Upexi, Inc. is a brand owner specialized in the development, manufacturing and distribution of consumer products. The Company focuses on direct-to-consumer and Amazon brands. The Company’s brands include LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, Gumi Labs, and Upexi Distribution. LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements. Gumi Labs manufactures gummies and other products supporting its health and wellness products, including those products manufactured with hemp ingredients. Upexi Distribution manages the warehousing and logistic needs of the Company and provides storage, consolidation, assembly, Amazon preparation, distribution and fulfilment services to its brands and its manufacturing operation.

企業情報

企業コードUPXI

会社名Upexi Inc

上場日Jun 24, 2021

設立日2018

最高経営責任者「CEO」- -

従業員数64

証券種類Ordinary Share

決算期末Jun 24

本社所在地3030 Rocky Point Drive

都市TAMPA

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号33607

電話番号17013535425

ウェブサイトhttps://upexi.com/

企業コードUPXI

上場日Jun 24, 2021

設立日2018

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Allan Marshall ,

Chairman of the Board, Chief Executive Officer

884.32K

+484.01%

Dr. Gene Salkind, M.D.

Independent Director

365.13K

+194.70%

Mr. Andrew J. Norstrud

Chief Financial Officer, Director

159.14K

+941.62%

Mr. Lawrence H. Dugan

Independent Director

--

Mr. Thomas Charles Williams

Independent Director

--

Mr. Valter Pinto

Investor Relations

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Allan Marshall ,

Chairman of the Board, Chief Executive Officer

884.32K

+484.01%

Dr. Gene Salkind, M.D.

Independent Director

365.13K

+194.70%

Mr. Andrew J. Norstrud

Chief Financial Officer, Director

159.14K

+941.62%

Mr. Lawrence H. Dugan

Independent Director

--

Mr. Thomas Charles Williams

Independent Director

--

Mr. Valter Pinto

Investor Relations

--

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q2

FY2025Q1

FY2024Q1

事業別USD

会社名

収益

比率

Internally manufactured

2.51M

62.68%

Contract manufactured

834.86K

20.84%

Purchased as finished goods

659.80K

16.47%

地域別USD

会社名

収益

比率

United States of America

3.95M

98.66%

Other

53.69K

1.34%

事業別

地域別

事業別USD

会社名

収益

比率

Internally manufactured

2.51M

62.68%

Contract manufactured

834.86K

20.84%

Purchased as finished goods

659.80K

16.47%

株主

更新時刻: Fri, Jul 18

株主統計

種類

株主統計

比率

Attestor Capital LLP

6.79%

GSR Growth Investments LP

4.58%

Novogratz (Michael E)

4.35%

Kathmere Capital Management

4.35%

Marshall (Allan)

1.76%

Other

78.17%

株主統計

比率

Attestor Capital LLP

6.79%

GSR Growth Investments LP

4.58%

Novogratz (Michael E)

4.35%

Kathmere Capital Management

4.35%

Marshall (Allan)

1.76%

Other

78.17%

種類

株主統計

比率

Individual Investor

8.02%

Hedge Fund

6.79%

Corporation

4.58%

Investment Advisor

4.38%

Investment Advisor/Hedge Fund

0.04%

Other

76.19%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

42

6.37M

16.79%

+6.01M

2025Q1

42

311.78K

28.56%

-35.31K

2024Q4

42

307.62K

23.29%

-32.82K

2024Q3

40

303.51K

29.16%

-55.91K

2024Q2

40

319.39K

30.68%

-45.58K

2024Q1

42

328.34K

32.32%

-46.59K

2023Q4

42

319.26K

31.43%

-34.26K

2023Q3

40

369.15K

37.28%

-46.01K

2023Q2

44

368.80K

38.85%

-28.58K

2023Q1

40

400.82K

45.14%

-64.50K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

GSR Growth Investments LP

2.31M

6.08%

+2.31M

--

Apr 24, 2025

Novogratz (Michael E)

2.19M

5.78%

+2.19M

--

Apr 24, 2025

Marshall (Allan)

884.32K

2.33%

+732.89K

+484.01%

Apr 17, 2025

Rudick (Brian Benjamin)

438.60K

1.16%

+438.60K

--

May 23, 2025

Salkind (Gene)

365.13K

0.96%

+241.23K

+194.70%

Apr 17, 2025

Norstrud (Andrew J)

159.14K

0.42%

+143.86K

+941.62%

Apr 17, 2025

BMO Nesbitt Burns Inc.

10.01K

0.03%

--

Mar 31, 2025

詳細を見る

8.150USD

Upexi Inc

8.150

概要

企業名

金融